Panel Discussion: Designing a Clinical Development Program to Support Future Market Access

Time: 4:55 pm
day: Conference Day One

Details:

• What are the critical market access steps when entering the clinic?
• Bridging the gap between early-phase development and commercial: how can market access push for payer- and patientrelevant endpoints to be included in phase 1 study designs?
• Practical advice when designing a clinical program for an intended first-in-class therapy
• Does engagement with Medicare look the same as commercial payers?

Speakers:

Laurel Todd Laurel has been involved in the pricing and reimbursement for novel therapies from both a commercial and policy perspective for over a decade.

Oswald Bentinck Oswald currently serves as Global Head of Value and Access at Rocket Pharmaceuticals, a clinical-stage biotech, advancing an integrated pipeline of LVV & AAV genetic Read more

Robert Rouse